Current Psychiatry Reports

, Volume 3, Issue 4, pp 288–294 | Cite as

Post-traumatic stress disorder: A review of recent findings

  • Soraya Seedat
  • Murray B. Stein


This article provides an update on recent findings in post-traumatic stress disorder (PTSD) with reference to pertinent epidemiologic, etiologic, diagnostic, and treatment advances in the past year. New studies serve to confirm high prevalence rates in the general population (7% to 12%), and high rates of secondary mood, anxiety, and substance use disorders. Recent substantive evidence has highlighted 1) the unique pattern of biological alteration in PTSD that distinguishes it from the normative stress response, and 2) the role of constitutional risk factors and trauma-related factors in determining disease expression after trauma exposure. The emergence of consistent data suggesting that medications (selective serotonin reuptake inhibitors) and psychotherapies (cognitive-behavior therapy) are effective in reducing core symptoms and improving quality of life, has reinforced optimism and more widespread use of these interventions in patients with PTSD.


Anxiety Disorder Selective Serotonin Reuptake Inhibitor Posttraumatic Stress Disorder Trauma Exposure Nefazodone 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Kardiner A: The Traumatic Neuroses of War. New York: Hoeber; 1941.Google Scholar
  2. 2.
    Keane TM: Symptomatology of Vietnam veterans with posttraumatic stress disorder. In Posttraumatic Stress Disorder: DSM IV and Beyond. Edited by Davidson JRT, Foa E. Washington, DC: American Psychiatric Press; 1993:99–111.Google Scholar
  3. 3.
    Summerfield D: The invention of post-traumatic stress disorder and the social usefulness of a psychiatric category. BMJ 2001; 322:95–98.PubMedCrossRefGoogle Scholar
  4. 4.
    Young A: The Harmony of Illusions: Inventing Posttraumatic Stress Disorder. Princeton, NJ: Princeton University Press; 1995.Google Scholar
  5. 5.
    Yehuda R, McFarlane AC: Conflict between current knowledge about posttraumatic stress disorder and its original conceptual basis. Am J Psychiatry 1995, 152:1705–1713.PubMedGoogle Scholar
  6. 6.
    American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, edn 4. Washington, DC: American Psychiatric Press; 1994.Google Scholar
  7. 7.
    Kessler RC, Sonnega A, Bromet E, et al.: Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1995, 52:1048–1060.PubMedGoogle Scholar
  8. 8.
    Solomon Z: Combat Stress Reaction: The Enduring Toll of War. New York: Plenum; 1993.Google Scholar
  9. 9.
    MacFarlane AC, Papay P: Multiple diagnoses in posttraumatic stress disorder in the victims of natural disaster. J Nerv Ment Dis 1992, 180:498–504.CrossRefGoogle Scholar
  10. 10.
    Kessler RC: Posttraumatic stress disorder: The burden to the individual and to society. J Clin Psychiatry 2000, 61(suppl):4–12. This is a review of the literature on prevalence studies of trauma exposure and conditional risk of post-traumatic stress disorder both in general population samples and focused samples of trauma victims.PubMedGoogle Scholar
  11. 11.
    Breslau N, Kessler RC, Chilcoat HD, et al.: Trauma and posttraumatic stress disorder in the community: the 1996 Detroit Area Survey of trauma. Arch Gen Psychiatry 1998, 55:626–632.PubMedCrossRefGoogle Scholar
  12. 12.
    Davidson JRT, Hughes D, Blazer D, et al.: Posttraumatic stress disorder in the community: an epidemiological study. Psychol Med 1991, 21:1–19.CrossRefGoogle Scholar
  13. 13.
    Perkonigg A, Kessler RC, Storz S, Wittchen HU: Traumatic events and post-traumatic stress disorder in the community: prevalence, risk factors and comorbidity. Acta Psychiatric Scandinavica 2000, 101:46–59.CrossRefGoogle Scholar
  14. 14.
    Stein MB, McQuaid JR, Pedrelli P, et al.: Posttraumatic stress disorder in the primary care medical setting. Gen Hosp Psychiatry 2000, 22:261–269. Study examining the prevalence and clinical characteristics of post-trauamatic stress disorder in a primary care sample.PubMedCrossRefGoogle Scholar
  15. 15.
    Samson AY, Bensen S, Beck A, et al.: Posttraumatic stress disorder in primary care. Fam Pract 1999, 48:222–227.Google Scholar
  16. 16.
    Bromet E, Sonnega A, Kessler RC: Risk factors for DSM-III-R posttraumatic stress disorder: findings from the National Comorbidity Survey. Am J Epidemiol 1998, 147:353–361.PubMedGoogle Scholar
  17. 17.
    Prigerson HG, Maciejewski PK, Rosenheck RA: Combat trauma: Trauma with highest risk of delayed onset and unresolved posttraumatic stress disorder symptoms, unemployment, and abuse among men. J Nerv Ment Dis 2001, 189:99–108.PubMedCrossRefGoogle Scholar
  18. 18.
    YehudaR: Risk factors for Posttraumatic Stress Disorder. Washington, DC: American Psychiatric Press Inc; 1999. This book provides a comprehensive review of biologic and psychosocial risk factors for post-traumatic stress disorder, and examines the relationship between the acute stress response and post-traumatic stress disorder.Google Scholar
  19. 19.
    Stein MB, Walker JR, Forde DR: Gender differences in susceptibility to posttraumatic stress disorder. Behav Res Ther 2000, 38:619–628.PubMedCrossRefGoogle Scholar
  20. 20.
    Yehuda R: Biology of posttraumatic stress disorder. J Clin Psychiatry 2000, 61:14–21.PubMedGoogle Scholar
  21. 21.
    Baker DG, West SA, Nicholson WE, et al.: Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder. Am J Psychiatry 1999, 156:585–588.PubMedGoogle Scholar
  22. 22.
    Charney DS, Deutsch AY, Krystal JH, et al.: Psychobiologic mechanisms of posttraumatic stress disorder. Arch Gen Psychiatry 1993; 50:294–299.Google Scholar
  23. 23.
    Delahanty DL, Raimonde AJ, Spoonster E: Initial urinary cortisol levels predict subsequent PTSD symptoms in motor vehicle accident victims. Biol Psychiatry 2000, 48:940–947.PubMedCrossRefGoogle Scholar
  24. 24.
    McFarlane AC, Atchison M, Yehuda R: The acute stress response following motor vehicle accident accidents and its relation to PTSD. Ann N Y Acad Sci 1997, 821:437–441.PubMedCrossRefGoogle Scholar
  25. 25.
    Yehuda R, McFarlane AC, Shalev AY: Predicting the development of posttraumatic stress disorder from the acute response to a traumatic event. Biol Psychiatry 1998, 44:1305–1313.PubMedCrossRefGoogle Scholar
  26. 26.
    Cohen H, Benjamin J, Kaplan Z, Kotler M: Administration of high-dose ketoconazole, an inhibitor of steroid synthesis, prevents posttraumatic anxiety in an animal model. Eur Neuropsychopharmacol 2000, 10:429–435.PubMedCrossRefGoogle Scholar
  27. 27.
    Bremner JD, Licinio J, Darnell A, et al.: Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder. Am J Psychiatry 1997, 154:624–629.PubMedGoogle Scholar
  28. 28.
    Southwick SM, Krystal JH, Morgan CA, et al.: Abnormal noradrenergic function in posttraumatic stress disorder. Arch Gen Psychiatry 1993, 50:266–274.PubMedGoogle Scholar
  29. 29.
    Southwick S, Morgan C, Charney D, High J: Yohimbine use in the natural setting: effects on posttraumatic stress disorder. Biol Psychiatry 1999, 46:442–444.PubMedCrossRefGoogle Scholar
  30. 30.
    Rasmusson AM, Hauger RL, Morgan CA, et al.: Low baseline and yohimbine-stimulated plasma neuropeptide Y (NPY) levels in combat-related PTSD. Biol Psychiatry 2000, 47:526–539.PubMedCrossRefGoogle Scholar
  31. 31.
    Geracioti TD Jr., Baker DG, Ekhator NN, et al.: Cerebrospinal fluid norepinephrine concentrations in post-traumatic stress disorder. Am J Psychiatry 2001, in press.Google Scholar
  32. 32.
    Nutt DJ: The psychobiology of posttraumatic stress disorder. J Clin Psychiatry 2000, 61(suppl):24–29PubMedGoogle Scholar
  33. 33.
    Chambers RA, Bremner JD, Moghaddam B, et al.: Glutamate and PTSD: toward a psychobiology of dissociation. Semin Clin Neuropsychiatry 1999, 4:274–281.PubMedGoogle Scholar
  34. 34.
    Ivesic S, Oruc L, Bell P: Psychotic symptoms in post-traumatic stress disorder. Mil Med 1999, 164:73–75.Google Scholar
  35. 35.
    Bremner JD, Randall P, Vermetten L, et al.: MRI-based measurement of hippocampal volume in posttraumatic stress disorder related to childhood physical and sexual abuse: a preliminary report. Biol Psychiatry 1997, 41:23–32.PubMedCrossRefGoogle Scholar
  36. 36.
    Gurvits TV, Shenton ME, Hokama H, et al.: Magnetic resonance imaging study of hippocampal volume in chronic, combat-related posttraumatic stress disorder. Biol Psychiatry 1996, 40:1091–1099.PubMedCrossRefGoogle Scholar
  37. 37.
    Stein MB, Koverola C, Hanna C, et al.: Hippocampal volume in women victimized by childhood sexual abuse. Psychol Med 1997, 27:951–959.PubMedCrossRefGoogle Scholar
  38. 38.
    Davis M, Whalen PJ: The amygdala: vigilance and emotion. Mol Psychiatry 2001, 6:13–34.PubMedCrossRefGoogle Scholar
  39. 39.
    Liberzon I, Taylor SF, Amdur R, Jung TD, et al.: Brain activation in PTSD in response to trauma-related stimuli. Biol Psychiatry 1999, 45:817–826.PubMedCrossRefGoogle Scholar
  40. 40.
    Semple WE, Goyer PF, McCormick R, et al.: Higher brain blood flow at amygdala and lower frontal cortex blood flow in PTSD patients with comorbid cocaine and alcohol abuse compare with controls. Psychiatry 2000, 63:65–74.PubMedGoogle Scholar
  41. 41.
    Rauch SL, Whalen PJ, Shin LM, et al.: Exaggerated amygdala response to masked facial stimuli in posttraumatic stress disorder: a functional MRI study. Biol Psychiatry 2000, 47:769–776.PubMedCrossRefGoogle Scholar
  42. 42.
    Pitman RK, Orr SP, Forgue DF, et al.: Psychophysiologic responses to combat imagery of Vietnam veterans with post-traumatic stress disorder versus other anxiety disorders. J Abnorm Psychol 1990, 99:49–54.PubMedCrossRefGoogle Scholar
  43. 43.
    Orr SP, Metzger LJ, Lasko NB, et al.: De novo conditioning in trauma-exposed individuals with and without post-traumatic stress disorder. J Abnorm Psychol 2000, 109:290–298.PubMedCrossRefGoogle Scholar
  44. 44.
    Shalev AY, Peri T, Brandes D, et al.: Auditory startle responses in trauma survivors with PTSD: a prospective study. Am J Psychiatry 2000, 157:255–261.PubMedCrossRefGoogle Scholar
  45. 45.
    Cohen H, Kotler M, Matar M, Kaplan Z: Normalization of heart rate variability in post-traumatic stress disorder patients following fluoxetine treatment: preliminary results. Isr Med Assoc J 2000, 2:296–301.PubMedGoogle Scholar
  46. 46.
    Tucker P, Smith KL, Marx B, et al.: Fluvoxamine reduces physiologic reactivity to trauma scripts in posttraumatic stress disorder. J Clin Psychopharmacol 2000, 20:367–372.PubMedCrossRefGoogle Scholar
  47. 47.
    Orr SP, Roth WT: Psychophysiological assessment: clinical applications for PTSD. J Affect Disord 2000, 61:225–240.PubMedCrossRefGoogle Scholar
  48. 48.
    Maes M, Mylle J, Delmiere L, Altamura C: Psychiatric morbidity and comorbidty following accidental manmade traumatic events: incidence and risk factors. European Arch Psychiatry Clin Neurosci 2000, 250:156–162.CrossRefGoogle Scholar
  49. 49.
    Giaconia RM, Reinherz HZ, Hauf AC, et al.: Comorbidity of substance use and post-traumatic stress disorders in a community sample of adolescents. Am J Orthopsychiatry 2000, 70:253–262.PubMedGoogle Scholar
  50. 50.
    Breslau N, Davis GC, Peterson EL, Schulz LR: A second look at comorbidity in victims of trauma: the posttraumatic stress disorder major depression connection. Biol Psychiatry 2000, 48:902–909. This retrospective and prospective analysis of data provides insight on the links between trauma exposure, post-traumatic stress disorder, and depression.PubMedCrossRefGoogle Scholar
  51. 51.
    Southwick SM, Yehuda R, Giller EL, et al.: Use of tricyclics and monoamine oxidase inhibitors in the treatment of PTSD: a quantitative review. In Catecholamine Function in Post-traumatic Stress Disorder: Emerging Concepts. Edited by Murburg MM. Washington, DC: American Psychiatric Press; 1994:293–305.Google Scholar
  52. 52.
    Baker DG, Diamond BI, Gilette G, et al.: A double-blind, randomised, placebo-controlled, multi-center study of brofaromine in the treatment of posttraumatic stress disorder. Psychopharmacol Berl 1995, 122:386–389.CrossRefGoogle Scholar
  53. 53.
    Katz RJ, Lott MH, Arbus P, et al.: Pharmacotherapy of post-traumatic stress disorder with a novel psychotropic. Anxiety 1994, 1:169–174.PubMedGoogle Scholar
  54. 54.
    Neal LA, Shapland W, Fox C: An open trial of moclobemide in the treatment of post-traumatic stress disorder. Int Clin Psychopharmacol 1997, 12:231–237.PubMedCrossRefGoogle Scholar
  55. 55.
    Stein DJ, Seedat S, van der Linden GJ, Zungu-Dirwayi N: Selective serotonin reuptake inhibitors in the treatment of post-traumatic stress disorder: a meta-analysis of randomised controlled trials. Int Clin Psychopharmacol 2000, 15(suppl):S31-S39.PubMedGoogle Scholar
  56. 56.
    Dow B, Kline N: Antidepressant treatment of posttraumatic stress disorder and major depression in veterans. Ann Clin Psychiatry 1997, 9:1–5.PubMedCrossRefGoogle Scholar
  57. 57.
    Brady K, Pearlstein T, Asnis GM, et al.: Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA 2000, 283:1837–1844.PubMedCrossRefGoogle Scholar
  58. 58.
    Connor KM, Sutherland SM, Tupler LA, et al.: Fluoxetine in posttraumatic stress disorder. Randomized, double-blind study. Br J Psychiatry 1999, 175:17–22.PubMedGoogle Scholar
  59. 59.
    Fernandez M, Pissiota A, Frans O, et al.: Brain function in a patient with torture related post-traumatic stress disorder before and after fluoxetine treatment: a positron emission tomography provocation study. Neurosci Letters 2001, 297:101–104.CrossRefGoogle Scholar
  60. 60.
    Davis LL, Nugent AL, Murray J, et al.: Nefazodone treatment for chronic posttraumatic stress disorder: an open trial. J Clin Psychopharmacol 2000, 20:159–164.PubMedCrossRefGoogle Scholar
  61. 61.
    Zisook S, Chentsova-Dutton YE, Smith-Vaniz A, et al.: Nefazodone in patients with treatment-refractory posttraumatic stress disorder. J Clin Psychiatry 2000, 61:203–208.PubMedCrossRefGoogle Scholar
  62. 62.
    Hidalgo R, Hertzberg MA, Mellman T, et al.: Nefazodone in post-traumatic stress disorder: results from six open-label trials. Int Clin Psychopharmacol 1999, 14:61–68.PubMedCrossRefGoogle Scholar
  63. 63.
    Hertzberg MA, Feldman ME, Beckham JC, et al.: Trial of trazodone for posttraumatic stress disorder using a multiple baseline group design. J Clin Psychopharmacol 1996, 16:294–298.PubMedCrossRefGoogle Scholar
  64. 64.
    Connor KM, Davidson JR, Weisler RH, et al.: A pilot study of mirtazapine in post-traumatic stress disorder. Int Clin Psychopharmacol 1999, 14:29–31.PubMedCrossRefGoogle Scholar
  65. 65.
    Hamner MB, Frueh BC: Response to venlafaxine in a previously antidepressant treatment-resistant combat veteran with post-traumatic stress disorder. Int Clin Psychopharmacol 1998, 13:233–234.PubMedCrossRefGoogle Scholar
  66. 66.
    Kitchner I, Greenstein R: Low-dose lithium carbonate in the treatment of post traumatic stress disorder: brief communication. Mil Med 1985, 150:378–381.PubMedGoogle Scholar
  67. 67.
    Forster Pl, Schoenfield FB, Marmar CR, et al.: Lithium for irritability in post-traumatic stress disorder. J Trauma Stress 1995, 8:143–149.PubMedCrossRefGoogle Scholar
  68. 68.
    Lipper S, Davidson JRT, Grady TA, et al.: Preliminary study of carbamazepine in posttraumatic stress disorder. Psychosomatics 1986, 27:849–854.PubMedGoogle Scholar
  69. 69.
    Wolf ME, Alavi A, Mosnaim AD: Posttraumatic stress disorder in Vietnam veterans: clinical and EEG findings: possible therapeutic effects of carbamazepine. Biol Psychiatry 1988, 23:642–644.PubMedCrossRefGoogle Scholar
  70. 70.
    Looff D, Grimley P, Kuller F, et al.: Carbamazepine for PTSD. J Am Acad Child Adolesc Psychiatry 1995, 34:703–704.PubMedCrossRefGoogle Scholar
  71. 71.
    Fesler FA: Valproate in combat-related posttraumatic stress disorder. J Clin Psychiatry 1991, 52:361–364.PubMedGoogle Scholar
  72. 72.
    Macleod AD: Vigabatrin and posttraumatic stress disorder [letter]. J Clin Psychopharmacol 1996, 16:190–191.PubMedCrossRefGoogle Scholar
  73. 73.
    Berlant J: Open-label topiramate of post-traumatic stress disorder. Paper presented at: 39th Annual Meeting of the New Clinical Drug Evaluation Unit; June 1 to 4, 1999; Boca Raton, FL.Google Scholar
  74. 74.
    Hertzberg M, Butterfield MI, Feldman ME, et al.: A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder. Biol Psychiatry 1999, 45:1226–1229.PubMedCrossRefGoogle Scholar
  75. 75.
    Lovell K, Marks LM, Noshirvani H, et al.: Do cognitive and exposure treatments improve various PTSD symptoms differently? A randomised controlled trial. Behav Cogn Psychother 2001, 29:107–112.CrossRefGoogle Scholar
  76. 76.
    Hembree EA, Foa EB: Posttraumatic stress disorder: psychological factors and psychosocial interventions. J Clin Psychiatry 2000, 61(suppl):33–39.PubMedCrossRefGoogle Scholar
  77. 77.
    Tolin DF: A revised meta-analysis of psychosocial treatments for PTSD. Paper presented at: 33rd Annual Meeting of the Association for the Advancement of Behavior Therapy; November 1999; Toronto, Ontario, Canada.Google Scholar
  78. 78.
    Van Etten ML, Taylor S: Comparative efficacy of treatments for posttraumatic stress disorder: a meta-analysis. Clin Psychol Psychother 1998, 5:125–144.CrossRefGoogle Scholar
  79. 79.
    Zoellner LA, Goodwin ML, Foa EB: PTSD severity and health perceptions in female victims of sexual assault. J Trauma Stress 2000, 13:635–639.PubMedCrossRefGoogle Scholar
  80. 80.
    Greenberg PE, Sisitsky T, Kessler RC, et al.: The economic burden of anxiety disorders in the 1990s. J Clin Psychiatry 1999, 60:427–435.PubMedCrossRefGoogle Scholar
  81. 81.
    Zatzick DF, Weiss DS, Marmar CR, et al.: Posttraumatic stress disorder and functioning and quality of life outcomes in female Vietnam veterans. Mil Med 1997, 162:661–665.PubMedGoogle Scholar
  82. 82.
    Carlier IV, Gersons BPR: Partial posttraumatic stress disorder (PTSD): the issue of psychological scars and the occurrence of PTSD symptoms. J Nerv Ment Dis 1995, 183:107–109.PubMedCrossRefGoogle Scholar
  83. 83.
    Stein MB, Walker JR, Hazen AL, Forde DR: Full and partial posttraumatic stress disorder: findings from a community survey. Am J Psychiatry 1997, 154:1114–1119.PubMedGoogle Scholar
  84. 84.
    Frueh BC, Turner SM, Beidel DC, Cahill SP: Assessment of social functioning in combat veterans with PTSD. Aggression and Violent Behavior 2001, 6:79–90.CrossRefGoogle Scholar
  85. 85.
    Mendlowicz MV, Stein MB: Quality of life in individuals with anxiety disorders. Am J Psychiatry 2000, 157:669–682. This is a review of epidemiologic and clinical studies that have investigated quality of life in patients with post-trauamtic stress disorder, panic disorder, social phobia, obsessive-compulsive disorder, and generalized anxiety disorder.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 2001

Authors and Affiliations

  • Soraya Seedat
    • 1
  • Murray B. Stein
    • 1
  1. 1.Department of Psychiatry (0985)University of California, San DiegoLa JollaUSA

Personalised recommendations